In 2023, over *** million people in the United States had used methamphetamine in the past year. This statistic shows the number of people in the U.S. who have used methamphetamine in the past year from 2009 to 2023.

In 2023, around 16.1 million people in the United States had used methamphetamine in their lifetime. This statistic shows the number of people in the U.S. who have used methamphetamine in their lifetime from 2009 to 2023.

An annual average of nearly 8 White, non-Hispanic adults in the U.S. per 1,000 engaged in past year methamphetamine use between 2015 and 2018. The statistic illustrates the annual average rate of past-year methamphetamine use among adults in the U.S. between 2015 and 2018, by ethnicity.

The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 7,794 arrestees were interviewed during the second and third quarters of 2009. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2009, and ending September 30, 2009. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.

In 2023, nearly 1.6 million people in the United States used methamphetamine in the past month. This statistic shows the number of people in the U.S. who used methamphetamine in the past month from 2009 to 2023.

Dataset of Meth Usage by Gender Among San Diego County Arrestees from 2000 - 2021.

The Oklahoma Methamphetamine Data Initiative (OMDI) sought to examine the relationship between methamphetamine and violent crime. Both national and local drugs and crime data were collected to inform narcotics law enforcement intervention strategies. OMDI's goals are to establish procedures and metrics to evaluate the relationship between meth and violent crime; identify static and dynamic factors associated with violent crime stemming from meth use or distribution to improve community surveillance in Oklahoma; develop a regularly updated dashboard for law enforcement prevention/intervention deployment; and demonstrate the utility of this model for other states, rural areas, and Indian Country.

The study was conducted to provide information about markets for, distribution of, and use of methamphetamine in New York City, both inside and outside of the MSM (men who have sex with men)/gay community. The study used Respondent Driven Sampling to recruit 132 methamphetamine market participants. Each respondent participated in a one to two hour structured interview combining both qualitative and quantitative responses. Each respondent was invited to recruit three additional eligible participants. Data collected included demographics, social network data, the respondent's market participation in obtaining and providing methamphetamine, consumption of methamphetamine, and experience with the criminal justice system and crime associated with participation in methamphetamine markets.

Meth Point Of Care Test Kits Market Outlook

The global meth point of care test kits market size was estimated to be USD 1.2 billion in 2023, projected to reach USD 2.8 billion by 2032, growing at a robust CAGR of 9.5% during the forecast period. The increasing prevalence of methamphetamine abuse worldwide, coupled with the rising demand for rapid and accurate diagnostic solutions, is driving significant growth in this market. Governments and healthcare organizations are increasingly focusing on combating drug abuse, further propelling the demand for these test kits.

One of the primary growth factors for the meth point of care test kits market is the escalating prevalence of methamphetamine abuse. Methamphetamine, commonly known as meth, is a highly addictive stimulant that affects the central nervous system. The increasing incidence of methamphetamine usage across various demographics has led to a greater need for quick and reliable testing methods. This urgency to address the growing public health issue is pushing the demand for point of care test kits that can be used in multiple settings, including hospitals, clinics, and even home care.

Another significant driver for the market is advancements in diagnostic technologies. Modern meth point of care test kits are becoming more accurate, user-friendly, and quicker in delivering results. Innovations in biosensors, microfluidics, and lab-on-a-chip technology have significantly improved the efficiency and reliability of these test kits. Enhanced sensitivity and specificity of these tests allow for better detection rates, thereby increasing their adoption among healthcare providers and individuals alike.

The increasing awareness and education about the harmful effects of methamphetamine are also contributing to market growth. Public health campaigns and educational programs aimed at preventing drug abuse are encouraging more people to undergo testing. This heightened awareness is not only driving the demand for point of care test kits but also ensuring that more people have access to them. This trend is particularly notable in regions with high rates of methamphetamine abuse, where community-level interventions are promoting the use of these test kits.

In recent years, the use of Ketamine Test Kit has gained prominence in the realm of drug testing, particularly in settings where rapid and reliable results are crucial. Ketamine, a dissociative anesthetic, is increasingly being misused for its hallucinogenic effects, prompting the need for effective testing solutions. The introduction of Ketamine Test Kits has provided healthcare professionals and law enforcement agencies with a valuable tool for detecting ketamine use. These kits are designed to offer quick and accurate results, making them ideal for use in emergency situations and routine screenings. The growing awareness of ketamine misuse and the availability of these test kits are contributing to their increased adoption across various sectors.

From a regional perspective, North America currently holds the largest share in the meth point of care test kits market. This dominance is attributed to the high prevalence of methamphetamine abuse in the United States and Canada, coupled with strong governmental initiatives to combat drug abuse. However, the Asia Pacific region is expected to witness the highest growth rate, driven by increasing drug abuse cases, rising healthcare spending, and growing awareness about drug testing solutions. Europe, Latin America, and the Middle East & Africa are also anticipated to contribute significantly to market expansion through various public health initiatives and regulatory support.

Product Type Analysis

The meth point of care test kits market can be segmented by product type into urine test kits, saliva test kits, blood test kits, and others. Each type offers unique advantages and is suited for different testing environments and requirements. Urine test kits are the most widely used due to their non-invasive nature, ease of use, and cost-effectiveness. These kits are popular in both clinical and home care settings, providing reliable results with minimal discomfort to the user. The wide adoption of urine test kits is primarily driven by their high accuracy and ability to detect methamphetamine for a longer period after ingestion.

Saliva test kits are gaining traction due to their convenience and rapid results. These kits are particularly favored in settings where immedia

31471 Global import shipment records of Meth with prices, volume & current Buyer's suppliers relationships based on actual Global export trade database.

These data are part of NACJD's Fast Track Release and are distributed as they were received from the data depositor. The files have been zipped by NACJD for release, but not checked or processed except for the removal of direct identifiers. Users should refer to the accompanying readme file for a brief description of the files available with this collection and consult the investigator(s) if further information is needed. In this study, researchers used capture-recapture sampling and multiple data sources to gauge the impact of drug trafficking in Quebec, Canada on the United States drug market. The main analyses were based on arrest data that were obtained for Quebec. In addition, analysis of the chemical composition and price assessments of the Quebec synthetic drugs was done. The study includes one SPSS data file (Quebec Arrest Data (Synthetic Drugs Cases, September 2014; n=20261)-ICPSR.sav ; n=20,261 ; 13 variables) and one Excel data file (Chemical composition of seized synthetic drugs.xls ; n=365 ; 14 variables). Spatial analyses of border seizure data was performed by the researchers, but these data are not available at this time. The data used for these analyses concerned synthetic drug seizures at Canadian borders from 2007 to 2012. The dataset was provided by the Canadian Border Services Agency (CBSA). For each seizure, the specific border crossing where the seizure was made was provided, as well as the value of the seizure (except for precursors), the country of origin and the type of drug seized. The types of drugs were classified into five types: (1) Precursors, (2) MDMA, (3) Amphetamine, (4) Methamphetamine and (5) Others. Most of the seizures (86.6 percent) were classified in this last category. The country of origin of the seizure was also provided.

Analysis of data that identify meth-contaminated houses, consisting of an initial screening dataset followed by a comprehensive sample of houses that fail screenings. Data were from a random selection of properties for sale in the Boulder, CO area. This permitted an estimate of the fraction of residential properties that would be deemed contaminated above cleanup standards by health agencies. Data from reports that were commissioned during the sales process and in possession of the authors was mined for relevant information.

Positive Meth Usage among Adult Male, Adult Female, and Juvenile Arrestees.

Financial overview and grant giving statistics of Northern California Crystal Meth Anonymous

This page, "Methamphetamine", is part of the NIST Chemistry WebBook. This site and its contents are part of the NIST Standard Reference Data Program.

Subscribers can find out export and import data of 23 countries by HS code or product’s name. This demo is helpful for market analysis.

The Meth Point-of-Care Test Kits market has emerged as a crucial component in addressing the challenges posed by methamphetamine use and its associated health risks. These test kits are designed for rapid and efficient testing in various settings, from healthcare facilities to homecare environments, allowing for imm

This statistic depicts the number of methamphetamine laboratory incidents from 2000 to 2019. According to the source, the number of incidents has decreased from 9,064 in 2000 to under one thousand in 2019.

Spreadsheet of calculations for incidence and cost of meth contaminated housing. Tabs for each state and U.S. with existing calculations. Users may modify data inputs or equations to assess other assumptions effect on calculated result.

A. SUMMARY This dataset includes unintentional drug overdose death rates by race/ethnicity by year. This dataset is created using data from the California Electronic Death Registration System (CA-EDRS) via the Vital Records Business Intelligence System (VRBIS). Substance-related deaths are identified by reviewing the cause of death. Deaths caused by opioids, methamphetamine, and cocaine are included. Homicides and suicides are excluded. Ethnic and racial groups with fewer than 10 events are not tallied separately for privacy reasons but are included in the “all races” total.

Unintentional drug overdose death rates are calculated by dividing the total number of overdose deaths by race/ethnicity by the total population size for that demographic group and year and then multiplying by 100,000. The total population size is based on estimates from the US Census Bureau County Population Characteristics for San Francisco, 2022 Vintage by age, sex, race, and Hispanic origin.

These data differ from the data shared in the Preliminary Unintentional Drug Overdose Death by Year dataset since this dataset uses finalized counts of overdose deaths associated with cocaine, methamphetamine, and opioids only.

B. HOW THE DATASET IS CREATED This dataset is created by copying data from the Annual Substance Use Trends in San Francisco report from the San Francisco Department of Public Health Center on Substance Use and Health.

C. UPDATE PROCESS This dataset will be updated annually, typically at the end of the year.

D. HOW TO USE THIS DATASET N/A

E. RELATED DATASETS Overdose-Related 911 Responses by Emergency Medical Services Preliminary Unintentional Drug Overdose Deaths San Francisco Department of Public Health Substance Use Services

F. CHANGE LOG

• 12/16/2024 - Updated with 2023 data. Asian/Pacific Islander race/ethnicity group was changed to Asian.
• 12/16/2024 - Past year totals by race/ethnicity were revised after obtaining accurate race/ethnicity for some decedents that were previously marked as “unknown” race/ethnicity.